Galvin Gaustad & Stein’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Galvin Gaustad & Stein's DGX Position: Q3 2026 in Review
Galvin Gaustad & Stein increased its Quest Diagnostics (DGX) stake by 0.08% in Q3 2026, buying an estimated $693 and bringing the position to 3,935 shares worth $917K. The position accounts for 0.07% of the portfolio, ranked #136.
Galvin Gaustad & Stein first reported a position in DGX in Q4 2020 and has held it in 24 quarters since. The position peaked at $28.3M in Q4 2021. 1,130 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Galvin Gaustad & Stein held 3,935 shares of Quest Diagnostics worth $917K as of Q3 2026.
- Galvin Gaustad & Stein bought 3 Quest Diagnostics shares in Q3 2026, an estimated $693.
- Quest Diagnostics made up 0.07% of Galvin Gaustad & Stein's portfolio in Q3 2026, its #136 holding.
- Galvin Gaustad & Stein first reported a position in Quest Diagnostics in Q4 2020 and has held it in 24 quarters since.
- Galvin Gaustad & Stein's Quest Diagnostics position peaked at $28.3M in Q4 2021.
- 1,130 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Galvin Gaustad & Stein's 13F filing for Q3 2026, filed 8 Oct 2026.